Requiring hospitals to report what they make from 340B drug discounts versus what they spend on charity care could be a first step toward tackling full-scale 340B program reform later, a senior Republican on the U.S. House committee with jurisdiction over 340B said last week.
Vice Chair Larry Bucshon (R-Ind.) of the Energy & Commerce Subcommittee on Health made that suggestion during a March 28 hearing on ways to foster transparency and competition in health care. (Editor’s note: This is a follow-up to our news alert about the hearing.)
Requiring hospitals to report what they make from 340B drug discounts versus what they spend on charity care could be a first step toward tackling full-scale 340B program reform later, a senior Republican on the U.S. House committee with jurisdiction […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.